HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent Glioblastoma
Clinical trial NCT03216499 · COMPLETED
Trial details
- NCT number
- NCT03216499
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-14
- Primary completion
- 2019-08-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.